European Journal of Dermatology
MENUsQuiz editorial: Latent tuberculosis infection: Update of diagnosis before the introduction of biologic drugs Volume 25, issue 6, November-December 2015
Authors
Dermatology Unit, Complejo Hospitalario Universitario Granada, Spain
- DOI : 10.1684/ejd.2016.2732
- Page(s) : 629-30
- Published in: 2015
Screening of latent tuberculosis infection (LTI) in patients who are going to undergo treatment with biologic drugs (TNF blockers and anti-IL-2/23) to manage moderate-to-severe psoriasis has become an important issue in countries such as Spain, with one of the highest tuberculosis incident rates of Western Europe (13 new cases per 100,000 persons-year, World Health Organization reports) [1]. Interferon-γ Release Assay (IGRA) has recently been introduced as a relevant diagnosis method which could [...]